Kidney Patient Advocates Back Kennedy’s Overhaul of Preventive Task Force

For years, the advocacy group has criticized the Task Force for what it describes as systemic inaction regarding the early detection of kidney-related conditions. With more than 37 million Americans living with kidney disease and millions more affected by interconnected metabolic and cardiovascular health issues, the AAKP argues that the new appointments prioritize the diverse medical expertise needed to challenge outdated screening protocols. AAKP President Edward V. Hickey III, a chronic kidney disease patient and Marine Corps veteran, stated that the organization expects the new appointees to move toward a more patient-centered model that integrates modern therapies and evidence-based prevention strategies.

Paul T. Conway, AAKP Vice President and a long-time transplant recipient, noted that the group is optimistic about the inclusion of experts familiar with rural health, AI-driven innovation, and early detection. The organization has spent years pushing for reforms while simultaneously mobilizing a national voting bloc known as KidneyVoters™, which saw over 500,000 participants in 2024. This push for federal oversight coincides with broader AAKP efforts to secure up to $1.8 billion in research funding through the National Institutes of Health and the Department of Defense. By shifting the focus of the Task Force, the group aims to reduce the economic and physical burdens of organ failure, marking a strategic pivot in their ongoing engagement with federal regulatory agencies.